Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessMarkets

Dr Reddy's to market aspirin, anti-coagulant drug in US

The aggrenox brand and the generic drug registered sales of approximately $183 million MAT (moving annual turnover) in the American market for the 12 months ending August 2018, the release added.

October 15, 2018 / 04:42 PM IST
Representative image

Representative image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dr Reddys Laboratories announced it has received the approval of the US Food and Drug Administration to market aspirin and dipyridamole capsules.

Aspirin is used to treat pain, fever or inflammation while dipyridamole is used as an anti-coagulant.

They are available in 25 mg/200 mg, a press release said.

Aggrenox is a registered trademark of pharmaceutical major Boehringer Ingelheim, the release said.

The aggrenox brand and the generic drug registered sales of approximately $183 million MAT (moving annual turnover) in the American market for the 12 months ending August 2018, the release added.

PTI
first published: Oct 15, 2018 04:32 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347